|
141 |
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study
Enthalten in Acta Neuropathologica Communications Bd. 10, 3.1.2022, Nr. 1, date:12.2022: 1-14
|
|
|
|
142 |
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival
Enthalten in Acta Neuropathologica Communications Bd. 10, 10.1.2022, Nr. 1, date:12.2022: 1-10
|
|
|
|
143 |
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutation
Enthalten in Acta neuropathologica Bd. 139, 15.11.2019, Nr. 2, date:2.2020: 403-406
|
|
|
|
144 |
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
Enthalten in Acta neuropathologica Bd. 136, 2.7.2018, Nr. 2, date:8.2018: 181-210
|
|
|
|
145 |
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
Enthalten in Radiation oncology Bd. 6, 13.9.2011, Nr. 1, date:12.2011: 1-5
|
|
|
|
146 |
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
Enthalten in Nature medicine Bd. 31, 25.3.2025, Nr. 5, date:5.2025: 1567-1577
|
|
|
|
147 |
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
Enthalten in Nature Bd. 566, 7.2.2019, Nr. 7745, date:2.2019: E13
|
|
|
|
148 |
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial
Enthalten in BMC cancer Bd. 10, 6.10.2010, Nr. 1, date:12.2010: 1-8
|
|
|
|
149 |
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
Enthalten in BMC cancer Bd. 10, 6.9.2010, Nr. 1, date:12.2010: 1-9
|
|
|
|
150 |
Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study
Enthalten in Acta neuropathologica Bd. 143, 31.3.2022, Nr. 5, date:5.2022: 609-612
|
|
Administration
